Advisor - Lab Automation Software Engineer at Eli Lilly and Company

San Diego, California, United States

Eli Lilly and Company Logo
Not SpecifiedCompensation
Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Biotechnology, Pharmaceuticals, HealthcareIndustries

Requirements

  • Ph.D. in Computer Science, Software Engineering, Bioengineering/Engineering with at least three years of industry experience
  • M.S. in Computer Science, Software Engineering, Bioengineering/Engineering with at least 10 years of experience
  • B.S. in Computer Science, Software Engineering, Bioengineering/Engineering with at least 13 years of experience (experience should include relevant industry experience, preferably in a pharmaceutical company or an automation provider)
  • Strong proficiency in Python, SQL, and JavaScript, with working knowledge of programming/scripting in C#, VBA, R, C++, MATLAB, and Bash
  • Experience with statistical analysis tools (JMP, SAS, R) and business intelligence platforms (Tableau, Power BI, Spotfire)
  • Expertise in best DevOps practices, including database management systems (DBMS), data warehousing, software development, cloud computing platforms (AWS, Azure), and version control tools (GitHub, GitLab)
  • Experience with lab digitalization technologies (IoT device integration, digital lab twins, automated usage and error reporting telemetry metrics) as well as autonomous lab systems and closed-loop learning frameworks (strongly preferred)
  • Familiarity with lab data platforms including Benchling, LabGuru, PostgreSQL, Genedata, or similar LIMS/ELN systems
  • Strong problem-solving skills and ability to work cross-functionally with scientific and engineering teams
  • Background in life sciences, pharmaceutical research, or high-throughput screening environments (preferred)

Responsibilities

  • Design and develop software applications that orchestrate complex automated laboratory workflows and closed-loop learning systems
  • Build data pipelines and visualization tools that provide real-time insights into lab operations and experimental outcomes
  • Implement machine learning models for visual inspection systems, predictive maintenance, and process optimization that enhance operational efficiency
  • Create digital lab infrastructure including IoT integrations, digital lab twin models, and telemetry monitoring systems
  • Develop and maintain integrations across multiple automation schedulers, LIMS, and data platforms
  • Ensure robust software deployment through best DevOps practices and cloud-based solutions

Skills

Lab Automation
Software Engineering
AI
Machine Learning
Robotics
Data Pipelines
Visualization Tools
Automated Workflows
Closed-Loop Systems
Laboratory Digitalization

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters
1876Year Founded
$1,180.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.
Potential construction delays in Indiana could affect GLP-1 drug production timelines.
Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.
Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.
FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.
Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.
Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI